Board consists of world-renowned computer-driven drug discovery experts to support Ventus’ physics-based and AI/ML-enabled ReSOLVE® platform WALTHAM, Mass. & MONTREAL — December 16, 2025 — (BUSINESS WIRE) — Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing multiple small-molecule programs for immunological, inflammatory, and neurological disorders, today announced the appointment of Georgia McGaughey, Ph.D., as the chair […] The post Ventus Therapeutics Appoints Georgia McGaughey, Ph.D., as Chair of Newly Formed ReSOLVE ® Scientific Advisory Board appeared first on Vent